<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>CurrentAnesthesia — Cardiothoracic &amp; vascular anesthesia</title>
<subtitle>The newest Briefs placed in Cardiothoracic &amp; vascular anesthesia.</subtitle>
<id>https://currentanesthesia.com/topics/cardiothoracic-vascular-anesthesia/feed.xml</id>
<link rel="self" type="application/atom+xml" href="https://currentanesthesia.com/topics/cardiothoracic-vascular-anesthesia/feed.xml"/>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/topics/cardiothoracic-vascular-anesthesia/"/>
<updated>2026-10-28T04:50:19.556Z</updated>
<author><name>CurrentAnesthesia</name><uri>https://currentanesthesia.com/topics/cardiothoracic-vascular-anesthesia/</uri></author>
<entry>
<title>Early postoperative non-steroidal anti-inflammatory drugs and anastomotic leakage after oesophagectomy</title>
<id>https://currentanesthesia.com/studies/early-postoperative-non-steroidal-anti-inflammatory-drugs-and-anastomotic-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/early-postoperative-non-steroidal-anti-inflammatory-drugs-and-anastomotic-2022/"/>
<published>2026-10-28T04:50:19.556Z</published>
<updated>2026-10-28T04:50:19.556Z</updated>
<summary>Cohort study · Br J Surg, 2022. Anastomotic leakage — NSAIDs vs No NSAIDs: OR 1.04 (95 per cent CI 0.97 to 1.10); stabilized IPTW</summary>
</entry>
<entry>
<title>Sex-specific differences in the standard of care for infrarenal abdominal aortic aneurysm repair, and risk of major adverse cardiovascular events and death</title>
<id>https://currentanesthesia.com/studies/sex-specific-differences-in-the-standard-of-care-for-infrarenal-abdominal-aortic-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/sex-specific-differences-in-the-standard-of-care-for-infrarenal-abdominal-aortic-2023/"/>
<published>2026-10-28T04:50:19.556Z</published>
<updated>2026-10-28T04:50:19.556Z</updated>
<summary>Cohort study · Br J Surg, 2023. MACED: Women 12.0 per cent; open repair 12.0 per cent; endovascular repair 4.9 per cent · Men 8.9 per cent; open repair 8.9 per cent; endovascular repair 2.9 per cent</summary>
</entry>
<entry>
<title>Cost-effectiveness of Fibrinogen Concentrate vs Cryoprecipitate for Treating Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients</title>
<id>https://currentanesthesia.com/studies/cost-effectiveness-of-fibrinogen-concentrate-vs-cryoprecipitate-for-treating-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/cost-effectiveness-of-fibrinogen-concentrate-vs-cryoprecipitate-for-treating-2023/"/>
<published>2026-10-28T04:49:16.800Z</published>
<updated>2026-10-28T04:49:16.800Z</updated>
<summary>Randomized controlled trial · JAMA Surg, 2023. Total 28-day cost, 28 days: Fibrinogen concentrate Median CAD $38 180 (IQR CAD $26 350 [USD $19 622]-CAD $65 080 [USD $48 463]) · Cryoprecipitate Median CAD $38 790 (IQR CAD $26 180 [USD $19 495]-CAD $70 380 [USD $52 409])</summary>
</entry>
<entry>
<title>Effect of High-Dose Selenium on Postoperative Organ Dysfunction and Mortality in Cardiac Surgery Patients: The SUSTAIN CSX Randomized Clinical Trial</title>
<id>https://currentanesthesia.com/studies/sustain-csx-effect-of-high-dose-selenium-on-postoperative-organ-dysfunction-and-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/sustain-csx-effect-of-high-dose-selenium-on-postoperative-organ-dysfunction-and-2023/"/>
<published>2026-10-28T04:49:16.800Z</published>
<updated>2026-10-28T04:49:16.800Z</updated>
<summary>Randomized controlled trial · JAMA Surg, 2023. Composite of days alive and free from organ dysfunction, first 30 days after cardiac surgery: Selenium median 29 (IQR 28-30) days · Placebo median 29 (IQR 28-30) days</summary>
</entry>
<entry>
<title>Effect of a Combined Drug Approach on the Severity of Ischemia-Reperfusion Injury During Liver Transplant: A Randomized Clinical Trial</title>
<id>https://currentanesthesia.com/studies/effect-of-a-combined-drug-approach-on-the-severity-of-ischemia-reperfusion-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/effect-of-a-combined-drug-approach-on-the-severity-of-ischemia-reperfusion-2023/"/>
<published>2026-10-28T04:44:26.953Z</published>
<updated>2026-10-28T04:44:26.953Z</updated>
<summary>Randomized controlled trial · JAMA Netw Open, 2023. Posttransplant peak serum AST level, within the first 72 hours: Combined drug approach geometric mean 1262.9 (95% CI 946.3-1685.4) U/L · Control geometric mean 1451.2 (95% CI 1087.4-1936.7) U/L</summary>
</entry>
<entry>
<title>Evaluation of Frailty Measures and Short-term Outcomes After Lung Transplantation</title>
<id>https://currentanesthesia.com/studies/evaluation-of-frailty-measures-and-short-term-outcomes-after-lung-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/evaluation-of-frailty-measures-and-short-term-outcomes-after-lung-2023/"/>
<published>2026-10-28T04:40:50.491Z</published>
<updated>2026-10-28T04:40:50.491Z</updated>
<summary>Cohort study · Chest, 2023. 1-year survival and hospital-free days (HFDs) in the first 90 days after transplantation: Frail by FI (FI ≥ 0.25) before transplantation 51.3%</summary>
</entry>
<entry>
<title>Levosimendan in patients undergoing extracorporeal membrane oxygenation after cardiac surgery: an emulated target trial using observational data</title>
<id>https://currentanesthesia.com/studies/levosimendan-undergoing-extracorporeal-membrane-oxygenation-after-cardiac-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/levosimendan-undergoing-extracorporeal-membrane-oxygenation-after-cardiac-2023/"/>
<published>2026-10-28T04:14:48.087Z</published>
<updated>2026-10-28T04:14:48.087Z</updated>
<summary>Cohort study · Crit Care, 2023. Time to successful VA-ECMO weaning — Levosimendan vs No levosimendan: HR for successful ECMO weaning 0.91 (CI 0.57; 1.45); p = 0.659; multivariable analysis</summary>
</entry>
<entry>
<title>Post-cardiac surgery fungal mediastinitis: clinical features, pathogens and outcome</title>
<id>https://currentanesthesia.com/studies/post-cardiac-surgery-fungal-mediastinitis-clinical-features-pathogens-and-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/post-cardiac-surgery-fungal-mediastinitis-clinical-features-pathogens-and-2023/"/>
<published>2026-10-28T04:14:48.087Z</published>
<updated>2026-10-28T04:14:48.087Z</updated>
<summary>Cohort study · Crit Care, 2023. Fungal mediastinitis incidence and hospital mortality: Patients developing fungal mediastinitis among 73,688 cardiac surgery procedures 40</summary>
</entry>
<entry>
<title>The low-dose colchicine in patients after non-CABG cardiac surgery: a randomized controlled trial</title>
<id>https://currentanesthesia.com/studies/the-low-dose-colchicine-in-patients-after-non-cabg-cardiac-surgery-a-randomized-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/the-low-dose-colchicine-in-patients-after-non-cabg-cardiac-surgery-a-randomized-2023/"/>
<published>2026-10-28T04:14:48.087Z</published>
<updated>2026-10-28T04:14:48.087Z</updated>
<summary>Randomized controlled trial · Crit Care, 2023. cTnT, postoperative 48 h: Colchicine median 0.3 (IQR 0.2-0.4) μg/L · Placebo median 0.4 (IQR 0.3-0.6) μg/L</summary>
</entry>
<entry>
<title>A comparison of the NeurOs® and the INVOS 5100C® cerebral oximeter during variations of the partial pressure of carbon dioxide and fractional inspiratory concentration of oxygen</title>
<id>https://currentanesthesia.com/studies/comparison-neuros-invos-5100c-cerebral-oximeter-during-variations-partial-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/comparison-neuros-invos-5100c-cerebral-oximeter-during-variations-partial-2023/"/>
<published>2026-10-28T04:08:44.882Z</published>
<updated>2026-10-28T04:08:44.882Z</updated>
<summary>Cohort study · J Clin Monit Comput, 2023. Agreement of ScO2 measurement (Bland-Altman bias and limits of agreement) during variations of PaCO2 and of SaO2 by FiO2: Bias, PaCO2 variation - 0.5%</summary>
</entry>
<entry>
<title>Intra-abdominal hypertension in cardiac surgery patients: a multicenter observational sub-study of the Accuryn registry</title>
<id>https://currentanesthesia.com/studies/intra-abdominal-hypertension-in-cardiac-surgery-patients-a-multicenter-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/intra-abdominal-hypertension-in-cardiac-surgery-patients-a-multicenter-2022/"/>
<published>2026-10-28T04:08:44.882Z</published>
<updated>2026-10-28T04:08:44.882Z</updated>
<summary>Secondary analysis · J Clin Monit Comput, 2022. IAH for at least 12 cumulative hours, by grade, first 48 h after cardiac surgery: IAH grade I ≥12 cumulative h 93% (128/137)</summary>
</entry>
<entry>
<title>Peak systolic myocardial velocity in patients undergoing surgical aortic valve replacement for severe aortic stenosis: prognostic value and natural course</title>
<id>https://currentanesthesia.com/studies/peak-systolic-myocardial-velocity-in-patients-undergoing-surgical-aortic-valve-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/peak-systolic-myocardial-velocity-in-patients-undergoing-surgical-aortic-valve-2022/"/>
<published>2026-10-28T04:08:44.882Z</published>
<updated>2026-10-28T04:08:44.882Z</updated>
<summary>Cohort study · J Clin Monit Comput, 2022. All-cause mortality, median follow-up 5.2 years: pre-S'LOW 12% · pre-S'HIGH 8%</summary>
</entry>
<entry>
<title>The impact of urine flow on urine oxygen partial pressure monitoring during cardiac surgery</title>
<id>https://currentanesthesia.com/studies/the-impact-of-urine-flow-on-urine-oxygen-partial-pressure-monitoring-during-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/the-impact-of-urine-flow-on-urine-oxygen-partial-pressure-monitoring-during-2022/"/>
<published>2026-10-28T04:08:44.882Z</published>
<updated>2026-10-28T04:08:44.882Z</updated>
<summary>Cohort study · J Clin Monit Comput, 2022. Patients included with valid PuO2 data (≤70% data discarded): CPB 81% · post-CPB 90% · pre-CPB 31%</summary>
</entry>
<entry>
<title>Acetaminophen pharmacokinetics in infants and children with congenital heart disease</title>
<id>https://currentanesthesia.com/studies/acetaminophen-pharmacokinetics-in-infants-and-children-with-congenital-heart-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/acetaminophen-pharmacokinetics-in-infants-and-children-with-congenital-heart-2022/"/>
<published>2026-10-28T04:04:03.147Z</published>
<updated>2026-10-28T04:04:03.147Z</updated>
<summary>Cohort study · Paediatr Anaesth, 2022. 2-compartment model PK parameter estimates (PPV%; 95% CI): Clearance CL, L.h-1.70 kg-1 15.3 (PPV 22.2%; 95% CI 13.8-16.7)</summary>
</entry>
<entry>
<title>Intraoperative blood product transfusion in pediatric cardiac surgery patients: A retrospective review of adverse outcomes</title>
<id>https://currentanesthesia.com/studies/intraoperative-blood-product-transfusion-in-pediatric-cardiac-surgery-patients-a-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/intraoperative-blood-product-transfusion-in-pediatric-cardiac-surgery-patients-a-2023/"/>
<published>2026-10-28T04:04:03.147Z</published>
<updated>2026-10-28T04:04:03.147Z</updated>
<summary>Cohort study · Paediatr Anaesth, 2023. Adverse outcomes, adjusted for age, cyanotic status, STAT score and CPB time: No association between transfusion of blood products and AKI or stroke</summary>
</entry>
<entry>
<title>Pharmacokinetics of dexmedetomidine in pediatric patients undergoing cardiac surgery with cardiopulmonary bypass</title>
<id>https://currentanesthesia.com/studies/pharmacokinetics-of-dexmedetomidine-in-pediatric-patients-undergoing-cardiac-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/pharmacokinetics-of-dexmedetomidine-in-pediatric-patients-undergoing-cardiac-2023/"/>
<published>2026-10-28T04:04:03.147Z</published>
<updated>2026-10-28T04:04:03.147Z</updated>
<summary>Research article · Paediatr Anaesth, 2023. Dexmedetomidine PK parameter estimates (95% CI), standardized to 70-kg person: Best model: two-compartment mammillary model with third compartment associated with CPB</summary>
</entry>
<entry>
<title>Ultrasound‐guided supraclavicular cannulation of left brachiocephalic versus right internal jugular vein: Comparative analysis of central venous catheter‐associated complications</title>
<id>https://currentanesthesia.com/studies/ultrasound-guided-supraclavicular-cannulation-left-brachiocephalic-right-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/ultrasound-guided-supraclavicular-cannulation-left-brachiocephalic-right-2022/"/>
<published>2026-10-28T04:04:03.147Z</published>
<updated>2026-10-28T04:04:03.147Z</updated>
<summary>Cohort study · Paediatr Anaesth, 2022. All complications: Left brachiocephalic vein 15.49% · Right internal jugular vein 13.65%</summary>
</entry>
<entry>
<title>Accuracy of Cardiac Output Measured by Fourth-Generation FloTrac and LiDCOrapid, and Their Characteristics Regarding Systemic Vascular Resistance in Patients Undergoing Cardiac Surgery</title>
<id>https://currentanesthesia.com/studies/accuracy-cardiac-output-measured-fourth-generation-flotrac-lidcorapid-their-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/accuracy-cardiac-output-measured-fourth-generation-flotrac-lidcorapid-their-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2023. Agreement with CITD: CIFT: r 0.62; bias -0.73 L/min/m2; limit of agreement -2.14-to-0.68 L/min/m2; percentage error 39.9% · CILR: r 0.58; bias -0.61 L/min/m2; limit of agreement -2.42-to-1.20 L/min/m2; percentage error 51.2%</summary>
</entry>
<entry>
<title>Assessment of a Quantra-Guided Hemostatic Algorithm in High-Bleeding-Risk Cardiac Surgery</title>
<id>https://currentanesthesia.com/studies/assessment-of-a-quantra-guided-hemostatic-algorithm-in-high-bleeding-risk-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/assessment-of-a-quantra-guided-hemostatic-algorithm-in-high-bleeding-risk-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Research article · J Cardiothorac Vasc Anesth, 2023. RBC units transfused, day 1: Quantra 2 (range or IQR as printed 0-5) units · Control 4 (range or IQR as printed 2-6) units</summary>
</entry>
<entry>
<title>Association Between Changes in Norepinephrine Infusion Rate and Urinary Oxygen Tension After Cardiac Surgery</title>
<id>https://currentanesthesia.com/studies/association-between-changes-in-norepinephrine-infusion-rate-and-urinary-oxygen-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/association-between-changes-in-norepinephrine-infusion-rate-and-urinary-oxygen-2022/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2022. Change in urinary PO2 from baseline, 30-to-60 minutes: NE increase least squares mean decrease 1.8 ± 0.5 mmHg; baseline urinary PO2 25.1 ± 1.1 mmHg · NE decrease least squares mean increase 2.6 ± 0.5 mmHg; baseline urinary PO2 22.7 ± 1.2 mmHg</summary>
</entry>
<entry>
<title>ClotPro Viscoelastometry Evaluation in Cardiac Surgery With Cardiopulmonary Bypass</title>
<id>https://currentanesthesia.com/studies/clotpro-viscoelastometry-evaluation-in-cardiac-surgery-with-cardiopulmonary-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/clotpro-viscoelastometry-evaluation-in-cardiac-surgery-with-cardiopulmonary-2022/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2022. Reproducibility and correlation: ClotPro: high reproducibility in most parameters of each test</summary>
</entry>
<entry>
<title>Coagulation Tests and Bleeding Classification After Cardiopulmonary Bypass: A Prospective Study</title>
<id>https://currentanesthesia.com/studies/coagulation-tests-and-bleeding-classification-after-cardiopulmonary-bypass-a-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/coagulation-tests-and-bleeding-classification-after-cardiopulmonary-bypass-a-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Diagnostic or prognostic study · J Cardiothorac Vasc Anesth, 2023. Classification of microvascular bleeding after CPB: PT: accuracy 62%; sensitivity 51%; specificity 70% · INR: accuracy 62%; sensitivity 48%; specificity 72% · Platelet count: accuracy 62%; sensitivity 62%; specificity 61%</summary>
</entry>
<entry>
<title>Cognitive Function Deterioration After Cardiopulmonary Bypass: Can Intraoperative Optimal Cerebral Regional Tissue Oxygen Saturation Predict Postoperative Cognitive Function?</title>
<id>https://currentanesthesia.com/studies/cognitive-function-deterioration-after-cardiopulmonary-bypass-can-intraoperative-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/cognitive-function-deterioration-after-cardiopulmonary-bypass-can-intraoperative-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2023. Postoperative cognitive function (Mini-Mental State Examination (MMSE), quantified electroencephalography (qEEG)), POD7 and POD60: MMSE: no significant decrease on POD7 vs preoperatively p = 0.09</summary>
</entry>
<entry>
<title>Comparative Efficacy of Adjuvant Nonopioid Analgesia in Adult Cardiac Surgical Patients: A Network Meta-Analysis</title>
<id>https://currentanesthesia.com/studies/comparative-efficacy-of-adjuvant-nonopioid-analgesia-in-adult-cardiac-surgical-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/comparative-efficacy-of-adjuvant-nonopioid-analgesia-in-adult-cardiac-surgical-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Meta-analysis · J Cardiothorac Vasc Anesth, 2023. Resting postoperative pain score, 24 hours — Acetaminophen vs Standard care and/or placebo: MD -0.66 points (95% CI -1.16 to -0.15); high confidence</summary>
</entry>
<entry>
<title>Comparison of Tools for Postoperative Pulmonary Complications After Cardiac Surgery</title>
<id>https://currentanesthesia.com/studies/comparison-of-tools-for-postoperative-pulmonary-complications-after-cardiac-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/comparison-of-tools-for-postoperative-pulmonary-complications-after-cardiac-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2023. Incidence of PPCs and diagnostic validity (AUC): Kroenke Score 262 (51.6%); AUC atelectasis 91.5%; AUC pneumonia 80.0%; AUC respiratory failure 75.9% · Melbourne Group Scale 111 (21.9%); AUC atelectasis 71.3%; AUC pneumonia 99.4%; AUC respiratory failure 88.5%</summary>
</entry>
<entry>
<title>Del Nido Cardioplegia in Adult Cardiac Surgery: Meta-Analysis of Randomized Clinical Trials</title>
<id>https://currentanesthesia.com/studies/del-nido-cardioplegia-in-adult-cardiac-surgery-meta-analysis-of-randomized-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/del-nido-cardioplegia-in-adult-cardiac-surgery-meta-analysis-of-randomized-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Meta-analysis · J Cardiothorac Vasc Anesth, 2023. Postoperative stroke and/or transient ischemic attack: Del Nido 9/467 (1.9%) · Control 25/540 (4.6%)</summary>
</entry>
<entry>
<title>Dexmedetomidine Sedation Combined With Remifentanil in MitraClip Procedures is Feasible and Improves Hemodynamics</title>
<id>https://currentanesthesia.com/studies/dexmedetomidine-sedation-combined-with-remifentanil-in-mitraclip-procedures-is-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/dexmedetomidine-sedation-combined-with-remifentanil-in-mitraclip-procedures-is-2022/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2022. Respiratory parameters: no differences between groups</summary>
</entry>
<entry>
<title>Effect of the Paravertebral Block on Chronic Postsurgical Pain After Thoracic Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials</title>
<id>https://currentanesthesia.com/studies/effect-of-the-paravertebral-block-on-chronic-postsurgical-pain-after-thoracic-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/effect-of-the-paravertebral-block-on-chronic-postsurgical-pain-after-thoracic-2022/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Meta-analysis · J Cardiothorac Vasc Anesth, 2022. Incidence of chronic postsurgical pain (CPSP), 3 months — PVB vs No block: OR 0.59 (95% CI 0.34-1.04); p = 0.07; I2 = 6.96%</summary>
</entry>
<entry>
<title>Enhanced Recovery After Surgery Is Associated With Reduced Hospital Length of Stay after Urgent or Emergency Isolated Coronary Artery Bypass Surgery at an Urban, Tertiary Care Teaching Hospital: An Interrupted Time Series Analysis With Propensity Score Matching</title>
<id>https://currentanesthesia.com/studies/enhanced-recovery-after-surgery-is-associated-reduced-hospital-length-stay-after-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/enhanced-recovery-after-surgery-is-associated-reduced-hospital-length-stay-after-2022/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2022. LOS (propensity-matched): Post-ERAS 9 (IQR 8-13) days · Pre-ERAS 10 (IQR 8-14) days</summary>
</entry>
<entry>
<title>Evaluation of Mitral-Aortic Flow Velocity Integral Ratio as a Tool to Differentiate Between Severe and Nonsevere Mitral Regurgitation</title>
<id>https://currentanesthesia.com/studies/evaluation-of-mitral-aortic-flow-velocity-integral-ratio-as-a-tool-to-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/evaluation-of-mitral-aortic-flow-velocity-integral-ratio-as-a-tool-to-2022/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Diagnostic or prognostic study · J Cardiothorac Vasc Anesth, 2022. Agreement in differentiating severe from nonsevere MR: Strong agreement between MAVIR and both RVol and EROA in the whole cohort, by TTE and TEE</summary>
</entry>
<entry>
<title>Evaluation of the Effects of an Extubation Protocol With Neostigmine on Duration of Mechanical Ventilation After Cardiac Surgery</title>
<id>https://currentanesthesia.com/studies/evaluation-of-the-effects-of-an-extubation-protocol-with-neostigmine-on-duration-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/evaluation-of-the-effects-of-an-extubation-protocol-with-neostigmine-on-duration-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2023. Postoperative duration of mechanical ventilation — Extubation protocol: IRR 0.82 (95% CI 0.72-0.94); p &lt; 0.01; 18% decrease</summary>
</entry>
<entry>
<title>General Anesthesia Versus Local Anesthesia in Patients Undergoing Transcatheter Aortic Valve Replacement: An Updated Meta-Analysis and Systematic Review</title>
<id>https://currentanesthesia.com/studies/general-anesthesia-local-anesthesia-undergoing-transcatheter-aortic-valve-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/general-anesthesia-local-anesthesia-undergoing-transcatheter-aortic-valve-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Meta-analysis · J Cardiothorac Vasc Anesth, 2023. 30-day mortality, 30 days — LA vs GA: RR 0.69; p &lt; 0.01</summary>
</entry>
<entry>
<title>Geometric Indices for Predicting Ischemic Mitral Regurgitation: Correlation of Mitral Valve Coaptation Area With Tenting Height, Tenting Area and Tenting Volume</title>
<id>https://currentanesthesia.com/studies/geometric-indices-predicting-ischemic-mitral-regurgitation-correlation-mitral-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/geometric-indices-predicting-ischemic-mitral-regurgitation-correlation-mitral-2022/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2022. Prediction of decreases in coaptation area: TV: R2 0.75 · TA: R2 0.48 · TH: R2 0.47</summary>
</entry>
<entry>
<title>Impact of Preoperative Hematocrit, Body Mass Index, and Red Cell Mass on Allogeneic Blood Product Usage in Adult Cardiac Surgical Patients: Report From a Statewide Quality Initiative</title>
<id>https://currentanesthesia.com/studies/impact-preoperative-hematocrit-body-mass-index-red-cell-mass-allogeneic-blood-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/impact-preoperative-hematocrit-body-mass-index-red-cell-mass-allogeneic-blood-2022/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2022. Allogeneic transfusion (adjusted) — BMI &lt;25 vs BMI ≥30: OR 1.26 (95% CI 1.08-1.39); adjusted</summary>
</entry>
<entry>
<title>Increasing obesity is associated with lower postoperative bleeding in coronary bypass patients</title>
<id>https://currentanesthesia.com/studies/increasing-obesity-is-associated-with-lower-postoperative-bleeding-in-coronary-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/increasing-obesity-is-associated-with-lower-postoperative-bleeding-in-coronary-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2023. Postoperative drainage: BMI &lt;18.5 637 (range 418-1108) mL · BMI ≥40 427 (range 295-620) mL</summary>
</entry>
<entry>
<title>Independent External Validation of a Preoperative Prediction Model for Delirium After Cardiac Surgery: A Prospective Observational Cohort Study</title>
<id>https://currentanesthesia.com/studies/independent-external-validation-of-a-preoperative-prediction-model-for-delirium-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/independent-external-validation-of-a-preoperative-prediction-model-for-delirium-2022/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2022. POD incidence and model discrimination: 0 points 12.6% · 1 point 22.8% · 2 points 25.8% · ≥3 points 35%</summary>
</entry>
<entry>
<title>Intraoperative Fascial Plane Blocks Facilitate Earlier Tracheal Extubation and Intensive Care Unit Discharge After Cardiac Surgery: A Retrospective Cohort Analysis</title>
<id>https://currentanesthesia.com/studies/intraoperative-fascial-plane-blocks-facilitate-earlier-tracheal-extubation-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/intraoperative-fascial-plane-blocks-facilitate-earlier-tracheal-extubation-2022/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2022. Tracheal extubation time — Block vs Intravenous analgesia: predicted extubation time difference (b coefficient) 9.29 hours (95% CI -11.98, -6.60); p = 0.022; after propensity score (PS) matching, weighted linear regression</summary>
</entry>
<entry>
<title>Intraoperative Noninvasive Left Ventricular Myocardial Work Indices in Patients Undergoing On-Pump Coronary Artery Bypass Surgery</title>
<id>https://currentanesthesia.com/studies/intraoperative-noninvasive-left-ventricular-myocardial-work-indices-in-patients-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/intraoperative-noninvasive-left-ventricular-myocardial-work-indices-in-patients-2022/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2022. LV myocardial work indices and GLS, T1 vs T2: T1 mean 1,224 ± 312 mmHg%; GLS -13.3 ± 3.0%; GCW 1,460 ± 312 mmHg%; GWW (median) 143 mmHg% (IQR 99-183); GWE (median) 89% (IQR 85-92) · T2 mean 940 ± 267 mmHg%; GLS -11.6 ± 3.1%; GCW 1,244 ± 336 mmHg%; GWW (median) 251 mmHg% (IQR 179-361); GWE (median) 80% (IQR 75-87)</summary>
</entry>
<entry>
<title>Machine Learning Models of Postoperative Atrial Fibrillation Prediction After Cardiac Surgery</title>
<id>https://currentanesthesia.com/studies/machine-learning-models-of-postoperative-atrial-fibrillation-prediction-after-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/machine-learning-models-of-postoperative-atrial-fibrillation-prediction-after-2022/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2022. AUC for postoperative AF prediction: Support-vector machine: AUC 0.777 (95% CI: 0.772-0.781) · Logistic regression: AUC 0.767 (95% CI: 0.762-0.772) · Gradient-boosting decision tree: AUC 0.765 (95% CI: 0.761-0.770)</summary>
</entry>
<entry>
<title>Perioperative Gelatin Use Is Associated With Increased Complication Rates and Does Not Prevent Postoperative Fluid Overload in Patients Undergoing Elective Cardiac Surgery</title>
<id>https://currentanesthesia.com/studies/perioperative-gelatin-use-is-associated-increased-complication-rates-does-not-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/perioperative-gelatin-use-is-associated-increased-complication-rates-does-not-2022/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2022. Postoperative FO: Gelatin 11.0% · Crystalloid 3.1%</summary>
</entry>
<entry>
<title>Perioperative Outcomes During Double-Lung Transplantation and Retransplantation in Cystic Fibrosis Patients: A Monocentric Cohort Study</title>
<id>https://currentanesthesia.com/studies/perioperative-outcomes-during-double-lung-transplantation-and-retransplantation-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/perioperative-outcomes-during-double-lung-transplantation-and-retransplantation-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2023. Main intraoperative and early postoperative features — reLgTx vs pLgTx; p = 0.02; longer second graft ischemic time</summary>
</entry>
<entry>
<title>Plasma Renin Activity Increases With Cardiopulmonary Bypass and is Associated With Vasoplegia After Cardiac Surgery</title>
<id>https://currentanesthesia.com/studies/plasma-renin-activity-increases-with-cardiopulmonary-bypass-and-is-associated-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/plasma-renin-activity-increases-with-cardiopulmonary-bypass-and-is-associated-2022/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2022. Plasma renin activity: Median plasma renin activity increased approximately 3 times from baseline immediately after surgery, remained elevated on POD 0, 1 and 2, began to downtrend on POD 3</summary>
</entry>
<entry>
<title>Platelet Function is Preserved After Moderate Cardiopulmonary Bypass Times But Transiently Impaired After Protamine</title>
<id>https://currentanesthesia.com/studies/platelet-function-is-preserved-after-moderate-cardiopulmonary-bypass-times-but-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/platelet-function-is-preserved-after-moderate-cardiopulmonary-bypass-times-but-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2023. Platelet function and count during CPB: No consistent impairment of platelet function during CPB (impedance aggregometry or flow cytometry)</summary>
</entry>
<entry>
<title>Point-of-Care Viscoelastic Hemostatic Assays in Cardiac Surgery Patients: Comparison of Thromboelastography 6S, Thromboelastometry Sigma, and Quantra</title>
<id>https://currentanesthesia.com/studies/point-of-care-viscoelastic-hemostatic-assays-in-cardiac-surgery-patients-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/point-of-care-viscoelastic-hemostatic-assays-in-cardiac-surgery-patients-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2023. Correlation with platelet count: ROTEM r 0.84 (CI 0.66-0.93); P p &lt; 0.0001 · Quantra r 0.83 (CI 0.64-0.92); P p &lt; 0.0001 · TEG 6S r 0.64 (CI 0.29-0.83); P p = 0.001</summary>
</entry>
<entry>
<title>Postcardiac Surgery Euglycemic Diabetic Ketoacidosis in Patients on Sodium-Glucose Cotransporter 2 Inhibitors</title>
<id>https://currentanesthesia.com/studies/postcardiac-surgery-euglycemic-diabetic-ketoacidosis-in-patients-on-sodium-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/postcardiac-surgery-euglycemic-diabetic-ketoacidosis-in-patients-on-sodium-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2023. eDKA in SGLT2i users: SGLT2i 8 (15.1%)</summary>
</entry>
<entry>
<title>Preoperative Risk Prediction Score for and In-Hospital Clinical Outcomes of Reperfusion Ventricular Fibrillation After Release of Aortic Cross-Clamps: A Retrospective Study</title>
<id>https://currentanesthesia.com/studies/preoperative-risk-prediction-score-hospital-clinical-outcomes-reperfusion-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/preoperative-risk-prediction-score-hospital-clinical-outcomes-reperfusion-2022/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2022. Predictors of reperfusion VF: Risk factors: weight &gt;55 kg, preoperative LV ejection fraction &lt;50%, prior stroke, hypertension, aortic valve replacement, HTK solution, ≥3 grafts in CABG</summary>
</entry>
<entry>
<title>Racial and Ethnic Differences in the Receipt of Regional Anesthesia Among Patients Undergoing Thoracic Surgery</title>
<id>https://currentanesthesia.com/studies/racial-and-ethnic-differences-in-the-receipt-of-regional-anesthesia-among-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/racial-and-ethnic-differences-in-the-receipt-of-regional-anesthesia-among-2022/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2022. Receipt of regional vs no regional anesthesia — Hispanic vs non-Hispanic: OR 0.61 (95% CI 0.46-0.80); p = 0.0003; adjusted</summary>
</entry>
<entry>
<title>Renal Dysfunction and Arrhythmia Association in Patients Receiving Milrinone After Cardiac Surgery</title>
<id>https://currentanesthesia.com/studies/renal-dysfunction-and-arrhythmia-association-in-patients-receiving-milrinone-2022/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/renal-dysfunction-and-arrhythmia-association-in-patients-receiving-milrinone-2022/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2022. New arrhythmias after initial milrinone infusion postcardiac surgery: Renal impairment 42.9% · No renal impairment 40.3%</summary>
</entry>
<entry>
<title>A Retrospective Pilot Comparison Trial Investigating Clinical Outcomes in Cardiac Surgical Patients Who Received Sugammadex Reversal During 2018 to 2021</title>
<id>https://currentanesthesia.com/studies/retrospective-pilot-comparison-investigating-clinical-outcomes-cardiac-surgical-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/retrospective-pilot-comparison-investigating-clinical-outcomes-cardiac-surgical-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2023. Extubation within 6 hours of end of surgery: Sugammadex 96.67% · No sugammadex 81.33%</summary>
</entry>
<entry>
<title>Rotational Thromboelastometry–Guided Use of Synthetic Blood Products in Cardiac Transplant Patients: A Retrospective Before-After Study</title>
<id>https://currentanesthesia.com/studies/rotational-thromboelastometry-guided-use-of-synthetic-blood-products-in-cardiac-2023/</id>
<link rel="alternate" type="text/html" href="https://currentanesthesia.com/studies/rotational-thromboelastometry-guided-use-of-synthetic-blood-products-in-cardiac-2023/"/>
<published>2026-10-28T03:56:35.329Z</published>
<updated>2026-10-28T03:56:35.329Z</updated>
<summary>Cohort study · J Cardiothorac Vasc Anesth, 2023. Time from CPB separation to skin closure — After vs Before: decrease 39.4 minutes (CI -73.1 to 123.5); p = 0.016; adjusted (multivariate linear regression)</summary>
</entry>
</feed>
